Free Trial

Dynatronics (DYNT) Competitors

Dynatronics logo
$0.09 -0.01 (-7.37%)
As of 03:06 PM Eastern

DYNT vs. TTOO, NDRA, XAGE, BJDX, NAOV, BBLG, IVF, LGMK, AVGR, and NUWE

Should you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include T2 Biosystems (TTOO), ENDRA Life Sciences (NDRA), Longevity Health (XAGE), Bluejay Diagnostics (BJDX), Nanovibronix (NAOV), Bone Biologics (BBLG), INVO Fertility (IVF), LogicMark (LGMK), Avinger (AVGR), and Nuwellis (NUWE). These companies are all part of the "medical equipment" industry.

Dynatronics vs. Its Competitors

Dynatronics (NASDAQ:DYNT) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

In the previous week, Dynatronics' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
Dynatronics Neutral
T2 Biosystems Neutral

Dynatronics has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.43, indicating that its stock price is 57% less volatile than the S&P 500.

Dynatronics has higher revenue and earnings than T2 Biosystems.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Dynatronics$33.60M0.03-$2.70M-$0.78-0.11
T2 Biosystems$7.68M0.32-$50.08MN/AN/A

4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 8.0% of Dynatronics shares are owned by company insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Dynatronics has a net margin of -8.35% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Dynatronics' return on equity.

Company Net Margins Return on Equity Return on Assets
Dynatronics-8.35% -41.81% -9.56%
T2 Biosystems -563.16%N/A -174.06%

T2 Biosystems has a consensus price target of $5.00, suggesting a potential upside of 4,210.34%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe T2 Biosystems is more favorable than Dynatronics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Dynatronics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
T2 Biosystems
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Dynatronics beats T2 Biosystems on 6 of the 11 factors compared between the two stocks.

Get Dynatronics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DYNT vs. The Competition

MetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$935K$98.90M$5.53B$9.13B
Dividend YieldN/AN/A5.06%4.01%
P/E Ratio-0.115.1128.5819.57
Price / Sales0.0376.99372.6479.65
Price / CashN/A18.4124.7227.51
Price / Book0.155.888.235.56
Net Income-$2.70M-$27.53M$3.19B$252.37M
7 Day PerformanceN/A1.82%5.46%3.11%
1 Month PerformanceN/A-3.89%9.39%11.74%
1 Year PerformanceN/A23.41%30.48%17.41%

Dynatronics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DYNT
Dynatronics
N/A$0.09
-7.4%
N/A-42.5%$935K$33.60M-0.11200Gap Down
TTOO
T2 Biosystems
2.2991 of 5 stars
$0.14
-3.6%
$5.00
+3,603.7%
-97.7%$2.84M$7.68M0.00180Gap Up
NDRA
ENDRA Life Sciences
2.9132 of 5 stars
$3.46
-2.3%
$50.00
+1,345.1%
-99.9%$2.61MN/A-0.0220High Trading Volume
XAGE
Longevity Health
N/A$2.35
-3.7%
N/AN/A$2.45M$50K0.0014News Coverage
Analyst Downgrade
Trading Halted
BJDX
Bluejay Diagnostics
1.2809 of 5 stars
$1.63
flat
N/A-94.8%$2.44MN/A0.009
NAOV
Nanovibronix
0.3272 of 5 stars
$0.92
-1.2%
N/A-88.5%$2.40M$2.56M-0.0720Gap Down
BBLG
Bone Biologics
0.9196 of 5 stars
$3.00
-14.0%
N/A-59.5%$1.90MN/A0.002Gap Down
IVF
INVO Fertility
N/A$0.81
-6.3%
N/AN/A$1.87M$6.59M-0.0210Gap Down
LGMK
LogicMark
0.1414 of 5 stars
$0.00
+13.3%
N/A-100.0%$1.73M$9.88M0.0020Gap Up
AVGR
Avinger
N/A$0.47
flat
N/AN/A$1.57M$7.65M-0.0470
NUWE
Nuwellis
3.1111 of 5 stars
$7.11
-13.8%
$714.00
+9,942.2%
-96.4%$860K$8.74M-0.3970Positive News
Trading Halted

Related Companies and Tools


This page (NASDAQ:DYNT) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners